Details for 2015151452
Up to date per 09.04.2026
Actions
Details for 2015151452
Granted/Registered
European Patent
28.10.2015 A
18.10.2017 B1
20.10.2008
US
106956 P
18.11.2008
US
115738 P
02.03.2009
US
156670 P
09.06.2009
US
185545 P
15.09.2009
US
242783 P
22.09.2009
US
244794 P
C12N 15/11 20060101AFI20150917BHEP
Owner
Alnylam Pharmaceuticals, Inc.300 Third Street, 3rd Floor Cambridge, MA 02142US
Representative
Representative
HÄUPL & ELLMEYER KG PATENTANWALTSKANZLEIMariahilfer Straße 501070 WienAT
Inventor
Sah, Dinah Wen-yeec/o Alnylam Pharmaceuticals Inc. 300 Third Street Third Floor Cambridge, MA 02142US
Hinkle, Gregoryc/o Alnylam Pharmaceuticals Inc. 300 Third Street Third Floor Cambridge, MA 02142US
Alvarez, Renec/o Alnylam Pharmaceuticals Inc. 300 Third Street Third Floor Cambridge, MA 02142US
Milstein, Stuartc/o Alnylam Pharmaceuticals Inc. 300 Third Street Third Floor Cambridge, MA 02142US
Chen, Qingminc/o Alnylam Pharmaceuticals Inc. 300 Third Street Third Floor Cambridge, MA 02142US
Information about Fees